SDC4 and neoplasm: This loss of syndecan-4 by tumour cells in NSGCTs was associated with nodal metastasis (P = 0.01), vascular and lymphatic invasion (P = 0.01), and disease stage (P = 0.01) (Figure 3 and Table 4).